Improving the efficacy and safety of medicines and nutraceuticals: modern methods — new challenges (Q19967): Difference between revisions
Jump to navigation
Jump to search
(Changed an Item) |
(Changed an Item) |
||||||||||||||
Property / EU contribution | |||||||||||||||
180,851,550.5 Czech koruna
| |||||||||||||||
Property / EU contribution: 180,851,550.5 Czech koruna / rank | |||||||||||||||
Normal rank | |||||||||||||||
Property / EU contribution | |||||||||||||||
7,234,062.02 Euro
| |||||||||||||||
Property / EU contribution: 7,234,062.02 Euro / rank | |||||||||||||||
Preferred rank | |||||||||||||||
Property / EU contribution: 7,234,062.02 Euro / qualifier | |||||||||||||||
exchange rate to Euro: 0.04 Euro
| |||||||||||||||
Property / EU contribution: 7,234,062.02 Euro / qualifier | |||||||||||||||
point in time: 10 January 2020
|
Revision as of 10:37, 19 June 2020
Project in Czech Republic financed by DG Regio
Language | Label | Description | Also known as |
---|---|---|---|
English | Improving the efficacy and safety of medicines and nutraceuticals: modern methods — new challenges |
Project in Czech Republic financed by DG Regio |
Statements
180,851,550.5 Czech koruna
0 references
212,766,530.0 Czech koruna
0 references
85 percent
0 references
1 January 2018
0 references
31 December 2022
0 references
Univerzita Karlova
0 references
11000
0 references
Projekt EFSA-CDN podpoří excelentní interdisciplinární výzkum na FaF UK s potenciálem tvorby kvalitních aplikovaných výsledků v delším časovém horizontu. Jeho cílem je zvýšit účinnost a bezpečnost léčiv a nutraceutik a zvýšit konkurenceschopnost VaV centra v mezinárodním měřítku, a to realizací klíčových aktivit podporujících kvalitní výzkum, rozvoj výzkumných týmů s účastí excelentních zahraničních vědců, modernizaci infrastruktury, internacionalizaci a řízení projektu ve všech jeho fázích. a. (Czech)
0 references
The EFSA-CDN project will support excellent interdisciplinary research on the UK FAF with the potential to produce quality applied results in the longer term. It aims to increase the effectiveness and safety of medicines and nutraceuticals and to increase the competitiveness of the Centre’s R & D internationally, through the implementation of key activities supporting quality research, the development of research teams with the participation of excellent foreign scientists, infrastructure modernisation, internationalisation and project management in all its stages. (English)
0 references
Identifiers
CZ.02.1.01/0.0/0.0/16_019/0000841
0 references